News & Resources
New Statement – Health is wealth: Policy makers must preserve investment to protect the health of EU citizens
BioMed Alliance has issued a new statement with a range of civil society organisations in the health field, expressing concerns regarding the potential cut of health funding in the next Multiannual Fi...
New Statement on Building a Stronger European Life Science Sector
The BioMed Alliance has responded to the European Commission call for evidence on a new strategy for European Life Sciences expressing considerations of healthcare professionals and researchers....
Open Letter from civil society urges the EU commission to adopt the 2025 EU4Health Work Programme
In a new statement, the BioMed Alliance has joined the EU4Health Civil Society Alliance to urge the Commission to ensure immediate adoption of the 2025 EU4Health Work Plan, to facilitate continued fun...
BioMed Alliance publishes new comprehensive review of regulatory framework for medical devices and IVDs
Brussels, 25 March 2025 – The Biomedical Alliance in Europe (BioMed Alliance), representing 35 leading medical and research societies, has published a comprehensive review detailing basic principles...
New multi stakeholder statement: Health Stakeholders advocate for enhanced collaboration in European Health Data Space (EHDS) Implementation
A coalition of 39 leading representatives from the European health community has publised a joint statement welcoming the publication of the European Health Data Space (EHDS) regulation in the EU's Of...
New article on Global Health in The Lancet Regional Health – Europe
The Biomedical Alliance in Europe published a new article in the Lancet Regional Health Europe on “Opportunities for European Medical Societies within the European Global Health Strategy.” The...
BioMed Alliance is looking for a trainee!
Would you like to start your career in the EU health policy field, and represent medic...
BioMed Alliance attends the EU Health Coalition Summit 2025
On 28 January, the BioMed Alliance team attended the EU Health Coalition Summit in Brussels. The event brought together the partners of the Coalition to listen on important discussions surrounding t...
New recommendations: How the Healthcare & Research Community Can Help Build the European Health Data Space
The BioMed Alliance has published a new policy document, How the Healthcare & Research Community Can Help Build the European Health Data Space, focusing on crucial recommendations for shaping and...
New Policy Recommendations focus on Key Shortcomings in MDR & IVDR
The BioMed Alliance has released two policy documents which include recommendations of healthcare professionals to address persisting challenges in the implementation of the Medical Device Regulation...
BioMed Alliance hosts Training Day on Regulatory Affairs for Clinicians and Researchers
On 27 November, the BioMed Alliance organized a Training Day for clinicians and researchers on key EU healthy policy files including the Health Technology Assessment (HTA), the Medical Devices Regulat...
Your Expertise Needed: Apply to EMA SAGs and EU MD/IVD Panels
The European Medicines Agency (EMA) is calling for experts to join its Scientific Advisory Groups (SAGs) as part of the upcoming mandate renewal. These advisory groups, managed by the Committee fo...
Annual General Assembly brings medical societies to Brussels
At the end of November, the BioMed Alliance organised 2 days of meetings for its members to discuss EU policies and regulations and ongoing and upcoming activities. A significant number of medical soc...
BioMed Alliance welcomes the introduction of the Q&A of article 10a in the IVD and MD Regulation
We are pleased to welcome the European Commission decision to include the Q&A on Article 10a, "The Information Obligation in Case of Interruption or Discontinuation of Supply of Certain Medical De...
BioMed Alliance Responds to new HTA Consultation
Following the Public Consultation on the draft implementing act on the joint scientific consultations on medicinal products for human use under the Health Technology Assessment (HTA) Regulation, the...
Plans made in haste to change Medical Device Regulations (MDR) risk further neglecting the needs of patients who rely on medical technologies.
Following the recent plenary session of the European Parliament, the BioMed Alliance publishes a new statement sharing its concerns about the debate on accelerating the evaluation of the Medical Devic...
EMA seeks experts for its medical devices expert panels and healthcare professionals working party
The European Medicines Agency (EMA) has launched a call for expression of interest for experts in medical devices and in-vitro diagnostics (IVDs) as part of the EXPAMED initiative. The purpose is to g...
Join the first BioMed Alliance training day on regulatory affairs
Have you always wanted to get more in-depth knowledge on how EU health policy making works and how you can have an impact? Then you should join the first BioMed Alliance training day on 27 November, w...
Join the BioMed Alliance Workshop on how the healthcare & research community can help build the European Health Data Space
BioMed Alliance is organising a public workshop on 'Building Bridges: how the healthcare & research community can help build the European Health Data Space' taking place on 15 October from 14:...
Introducing ESTRO – The newest BioMed Alliance member
BioMed Alliance is pleased to announce that the European Society for Radiotherapy and Oncology (ESTRO) has become its newest member.
Founded in 1980, ESTRO is a non-profit scientific organizati...
BioMed Alliance is looking for an intern
The BioMed Alliance is looking for an intern that will join our small team in Brussels to work as a Policy and Project Officer. The intern will get the chance to promote the interests of 35 European M...
Developing an online risk calculator uncertainty assessment for medical devices with limited evidence
Jasper van Egeraat, Bas Penning de Vries, Ewout Steyerberg High risk devices may be approved based on limited evidence from underpowered clinical studies. They may have a higher risk than commonly acc...
Enhancing BioMed Alliance Activities with the EXHALE operating grant
The BioMed Alliance has been awarded the EXHALE operating grant (BioMed Alliance EXpertise in Health Across Legislation at EU level) for 2024 under the EU4Health programme (grant agreement no 101...
Medical societies share their views on managing competing interests in HTA
The BioMed Alliance has replied to a public consultation on HTA on procedural rules for assessing and managing conflicts of interest. In the reply prepared by the HTA Working Group, the Alliance welco...